AN2 Therapeutics Inc（ANTX）の株価予測ANTXAN2 Therapeutics Inc

Alphio's ANTX stock price prediction model matches the current AN2 Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.94 (-0.26%). The 1-week path is $3.93 (-0.75%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

ANTX is a good buy right now due to its recent FDA clearance for the epetraborole drug, which is expected to drive future growth. The current price is $4.35, significantly below the analyst target of $9, suggesting a potential upside of over 100%. Additionally, the stock has shown a strong year-to-date change of +291.89%, indicating robust momentum. However, a risk to consider is the company's ongoing net losses, which reached $10.03 million in Q1 2026, reflecting the need for continued investment in R&D.

AN2 Therapeutics Inc (ANTX) last closed at $3.9549999, losing -6.94%. These facts feed the 1-day and 1-week ANTX price prediction above.